Also known as: Semka Technologies
Blood testing device for early diagnosis of cancer and treatmentβ¦
Company is active
Event Year: 2016
Company is active
Event Year: 2016
Delee is an innovative medical device company focused on revolutionizing cancer diagnostics and treatment monitoring. They have engineered a cutting-edge blood-testing device designed for the early detection of cancer. This device operates by isolating and analyzing circulating tumor cells (CTCs) present in the bloodstream, providing critical insights for timely intervention and personalized treatment strategies. Delee's technology aims to enhance the accuracy and efficiency of cancer management, ultimately improving patient outcomes.
Delee is an innovative medical device company focused on revolutionizing cancer diagnostics and treatment monitoring. They have engineered a cutting-edge blood-testing device designed for the early detection of cancer. This device operates by isolating and analyzing circulating tumor cells (CTCs) present in the bloodstream, providing critical insights for timely intervention and personalized treatment strategies. Delee's technology aims to enhance the accuracy and efficiency of cancer management, ultimately improving patient outcomes.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2017
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2017
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 18
Hiring: No
Team size: 18
Hiring: No